The forecast for liver malignant neoplasms mortality in Brazil indicates a year-on-year increase from 2024 through 2028. In 2023, the mortality figure was reported lower than any forecasted year from 2024 onwards. Specifically, the data shows an incremental rise in male deaths from 6.65 thousand in 2024 to 7.16 thousand by 2028, with a consistent upward trajectory. The average compound annual growth rate (CAGR) over these five years highlights a steady progression in mortality rates.
Looking forward, trends to monitor include advancements in medical research for liver cancer treatment, early detection initiatives, and public health interventions. Additionally, lifestyle factors prevalent in Brazil could influence mortality rates, as could changes in healthcare access and quality.
